Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
The U.S. labor market continues to have resilience. The number of job openings in January JOLTS rose to 6.9 million.
US Stock Market Move | Apple Inc. lowers commission rate for Chinese App Store; Tencent (ADR) up nearly 2% in early trading.
US Stock Market Move | "The launch of the new AI model 'Avocado' by Meta (META.US) is postponed, causing a nearly 3% drop in early trading."
The U.S. labor market continues to have resilience. The number of job openings in January JOLTS rose to 6.9 million.
US Stock Market Move | Apple Inc. lowers commission rate for Chinese App Store; Tencent (ADR) up nearly 2% in early trading.
US Stock Market Move | "The launch of the new AI model 'Avocado' by Meta (META.US) is postponed, causing a nearly 3% drop in early trading."
RECOMMEND
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026
